Showing 20 of 136 recruiting trials for “plasmablastic-lymphoma”
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
👨⚕️ Sanbin Wang, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jun 2024View details ↗
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
👨⚕️ Jianxiang Wang, Dr, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2024View details ↗
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Vitamin A and D Supplementation in Allogeneic HCT
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
👨⚕️ Xiaowen Tang, Ph.D, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2024View details ↗
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
RecruitingNCT06025682 ↗
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
👨⚕️ Livio Pagano, Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Roma📍 1 site📅 Started Apr 2024View details ↗
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
👨⚕️ Aimee C. Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Feb 2024View details ↗
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Universal 4SCAR7U Targeting CD7-positive Malignancies
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →